Abstract
In this article, we explored the level of knowledge and practice of licensed dentists in the United Arab Emirates regarding managing patients on antithrombotic medications. Moreover, to assess the need for educational intervention in this area is one of the objectives. A total of 502 dentists answered 22 close-ended questionnaires. The sample size was determined based on the registry of the Ministry of Health. Only 5.6 and 5.9% showed satisfactory overall awareness about aspirin and plavix, respectively, as drugs may hamper hemostasis. A substantial proportion of dentists consider aspirin (63.1%) and clopidogrel (52.2%) discontinuation before treatment. More than one-third of the participants shall not consider extracting teeth before physician approval, and one-quarter to one-third of them refer patients on such medications to oral surgeons to perform tooth extraction. Most respondents did not adequately answer the questions about the additional hemostatic measures and postoperative analgesia. A significantly high number of participants (n = 440, 87.6%) want to attend updated courses on the dental management of such patients. The dentists demonstrate a contrasting diversity of knowledge and practice approaches to patient management on antiplatelet agents. There is an apparent demand to raise understanding of the evidence-based management of a patient on such medications. It is vital to keep formalized training sessions and provide the necessary expertise to students and dentists to prevent unwanted complications.
Highlights
Dental practitioners commonly encounter patients with chronic illnesses
In this article, we explored the level of knowledge and practice of licensed dentists in the United Arab Emirates regarding managing patients on antithrombotic medications
The use of oral antithrombotic or antiplatelet agents such as aspirin and clopidogrel as well as anticoagulant such as warfarin has been rising consistently over the last decades to minimize the risk of complications of diabetes, hypertension, ischemic heart diseases, and cerebrovascular diseases.[1]
Summary
Dental practitioners commonly encounter patients with chronic illnesses. These patients are often on long-term medications to control these diseases and to prevent their serious complications. The use of oral antithrombotic or antiplatelet agents such as aspirin and clopidogrel as well as anticoagulant such as warfarin has been rising consistently over the last decades to minimize the risk of complications of diabetes, hypertension, ischemic heart diseases, and cerebrovascular diseases.[1] It was estimated that more than 40 percent of the U.S population. Knowledge and Practice of Dentists Managing Patients on Antithrombotic Medications Gaballah, Hassan older than 40 years receive antiplatelet medications, and nearly one-tenth of U.S patients are on warfarin.[2]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
